Position in PFE
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$359,225
+$30,353 QoQ
Shares Held
14,918
+27.4% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.34%
of 13F equity value
Holder Rank
#1,988
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Acorn Wealth Advisors, LLC holds $4,229,876 across 7 Drug Manufacturers - General names. PFE ranks #6 (8.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
3,833 | $973,467 | |
| 2 | MRK |
Merck & Co., Inc.
|
6,368 | $818,288 | |
| 3 | LLY |
ELI LILLY & Co
|
620 | $743,646 | |
| 4 | BMY |
Bristol Myers Squibb Co
|
8,764 | $504,981 | |
| 5 | ABBV |
AbbVie Inc.
|
1,979 | $497,995 | |
| 6 | PFE |
Pfizer Inc
This page
|
14,918 | $359,225 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
2,630 | $332,274 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $359,225 | 14,918 | Shares | Sole | 2026-07-30 | |
| 2026-03-31 | $328,872 | 11,712 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $307,963 | 12,368 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $291,975 | 11,459 | Shares | Sole | 2025-10-31 | |
| 2025-06-30 | $322,052 | 13,286 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $355,342 | 14,023 | Shares | Sole | 2025-05-01 | |
| 2024-12-31 | $376,619 | 14,196 | Shares | Sole | 2025-02-04 | |
| 2024-09-30 | $387,332 | 13,384 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $355,485 | 12,705 | Shares | Sole | 2024-07-30 | |
| 2024-03-31 | $289,127 | 10,419 | Shares | Sole | 2024-04-26 | |
| 2023-12-31 | $301,316 | 10,466 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $359,363 | 10,834 | Shares | Sole | 2023-11-07 | |
| 2023-06-30 | $397,061 | 10,825 | Shares | Sole | 2023-08-02 | |
| 2023-03-31 | $423,218 | 10,373 | Shares | Sole | 2023-05-09 | |
| 2022-12-31 | $530,590 | 10,355 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $448,496 | 10,249 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $535,520 | 10,214 | Shares | Sole | 2022-08-08 | |
| 2022-03-31 | $542,446 | 10,478 | Shares | Sole | 2022-05-03 | |
| 2021-12-31 | $564,636 | 9,562 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $408,767 | 9,504 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $375,975 | 9,601 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $350,344 | 9,670 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $348,517 | 9,468 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $347,291 | 9,463 | Shares | Sole | 2020-11-04 | |
| 2020-06-30 | $315,457 | 9,647 | Shares | Sole | 2020-08-19 | |
| 2020-03-31 | $314,192 | 9,626 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||